title: Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections.
abstract: This comparison of intermittent versus extended-infusion piperacillin-tazobactam among patients with Gram-negative infections revealed similar mortality and length of stay. Outcomes remained similar when stratified by MIC value.
authors.affiliation: Medical Center of Plano, TX 75075, USA.
authors.forename: Gita Wasan
authors.initials: GW
authors.lastname: Patel
authors.forename: Nimish
authors.initials: N
authors.lastname: Patel
authors.forename: Asma
authors.initials: A
authors.lastname: Lat
authors.forename: Kristen
authors.initials: K
authors.lastname: Trombley
authors.forename: Sam
authors.initials: S
authors.lastname: Enbawe
authors.forename: Kelli
authors.initials: K
authors.lastname: Manor
authors.forename: Raymond
authors.initials: R
authors.lastname: Smith
authors.forename: Thomas P
authors.initials: TP
authors.lastname: Lodise
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D007262:Infusions, Intravenous / Q000379:methods; D007902:Length of Stay; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010397:Penicillanic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010878:Piperacillin / Q000008:administration & dosage* / Q000627:therapeutic use; D000078142:Tazobactam; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D010397:Penicillanic Acid; D000078142:Tazobactam; D010878:Piperacillin